The
report " Cytomegalovirus (HHV-5) Infections Global Clinical
Trials Review, H1, 2016 ", has been prepared based on an
in-depth market analysis with inputs from industry experts.
GlobalData's
clinical trial report, Cytomegalovirus (HHV-5) Infections Global
Clinical Trials Review, H1, 2016" provides an overview of
Cytomegalovirus (HHV-5) Infections clinical trials scenario. This
report provides top line data relating to the clinical trials on
Cytomegalovirus
(HHV-5) Infections.
Report includes an overview of trial numbers and their average
enrollment in top countries conducted across the globe. The report
offers coverage of disease clinical trials by region, country (G7 &
E7), phase, trial status, end points status and sponsor type. Report
also provides prominent drugs for in-progress trials (based on number
of ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective
counter
strategies to gain competitive advantage.
Download
Sample copy of this Report @
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons
to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Browse All reports Of this
Category: www.marketresearchreports.biz/category/109
Table
of Content :
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top
Five Countries Contributing to Clinical Trials in Europe 11
Top
Countries Contributing to Clinical Trials in North America 12
Top
Countries Contributing to Clinical Trials in Middle East and Africa
13
Top
Countries Contributing to Clinical Trials in Central and South
America 14
Clinical
Trials by G7 Countries: Proportion of Cytomegalovirus (HHV-5)
Infections to Infectious Disease Clinical Trials 15
Clinical
Trials by Phase in G7 Countries 17
Clinical
Trials in G7 Countries by Trial Status 18
Clinical
Trials by E7 Countries: Proportion of Cytomegalovirus (HHV-5)
Infections to Infectious Disease Clinical Trials 19
Clinical
Trials by Phase in E7 Countries 20
Clinical
Trials in E7 Countries by Trial Status 21
Clinical
Trials by Phase 22
In
Progress Trials by Phase 23
Clinical
Trials by Trial Status 24
Clinical
Trials by End Point Status 25
Subjects
Recruited Over a Period of Time 26
Clinical
Trials by Sponsor Type 27
Prominent
Sponsors 28
Top
Companies Participating in Cytomegalovirus (HHV-5) Infections
Therapeutics Clinical Trials 29
Prominent
Drugs 31
Latest
Clinical Trials News on Cytomegalovirus (HHV-5) Infections 32
Feb
21, 2016: Fate Therapeutics to Present Preclinical Data for ProTmune
at 2016 BMT Tandem Meetings 32
Feb
20, 2016: Chimerix Announces Presentation of Detailed Results From
Phase 3 SUPPRESS Trial at BMT Tandem Meetings 32
Clinical
Trial Profile Snapshots 35
Appendix
205
Abbreviations
205
Definitions
205
Research
Methodology 206
Secondary
Research 206
About
GlobalData 207
Contact
Us 207
Disclaimer
207
Source
208
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
us:
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment